Trial intelligence / Profile preview

Impact of Sweeteners on the Addictive Threshold of Nicotine

NCT07771725Phase 1Not yet recruiting

Sponsor
Yale University
Start
Sep 2026
Primary completion
Sep 2029
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of nicotine in Tobacco Use Disorder (TUD) (4 arms), sponsored by Yale University. Primary endpoints: Drug Discrimination Scale and Drug Effects Questionnaire pleasurable effects. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

nicotine
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT07771725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07771725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call